PineBridge Investments’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$566K Buy
+7,877
New +$607K ﹤0.01% 430
2025
Q4
Sell
-52,593
Closed -$3.96M 530
2025
Q3
$3.96M Buy
+52,593
New +$3.6M 0.03% 303
2024
Q4
Sell
-99,961
Closed -$6.29M 722
2024
Q3
$6.29M Sell
99,961
-5,204
-5% -$304K 0.05% 279
2024
Q2
$6.21M Sell
105,165
-311,634
-75% -$19.5M 0.05% 278
2024
Q1
$33.2M Buy
416,799
+92,589
+29% +$7.07M 0.26% 83
2023
Q4
$25.6M Sell
324,210
-89,860
-22% -$6.4M 0.24% 107
2023
Q3
$28.9M Sell
414,070
-88,560
-18% -$6.27M 0.32% 82
2023
Q2
$34.7M Sell
502,630
-29,019
-5% -$2.06M 0.37% 66
2023
Q1
$39.5M Buy
531,649
+47,348
+10% +$3.97M 0.45% 52
2022
Q4
$45.1M Buy
484,301
+3,437
+0.7% +$332K 0.55% 43
2022
Q3
$45.9M Buy
480,864
+116
+0% +$11.5K 0.59% 32
2022
Q2
$44.5M Buy
480,748
+341,588
+245% +$33.3M 0.56% 35
2022
Q1
$14.1M Buy
139,160
+137,198
+6,993% +$14.4M 0.15% 160
2021
Q4
$202K Sell
1,962
-176
-8% -$16.3K ﹤0.01% 584
2021
Q3
$181K Sell
2,138
-1,015
-32% -$85K ﹤0.01% 533
2021
Q2
$263K Sell
3,153
-378,916
-99% -$31M ﹤0.01% 572
2021
Q1
$28.7M Buy
382,069
+48,170
+14% +$3.51M 0.37% 55
2020
Q4
$22.8M Sell
333,899
-5,132
-2% -$334K 0.35% 66
2020
Q3
$19.8M Buy
339,031
+14,392
+4% +$896K 0.34% 72
2020
Q2
$21.1M Sell
324,639
-19,064
-6% -$1.2M 0.4% 61
2020
Q1
$20.4M Sell
343,703
-5,362
-2% -$358K 0.48% 46
2019
Q4
$25.9M Buy
349,065
+113,312
+48% +$7.96M 0.4% 61
2019
Q3
$14.9M Buy
235,753
+118,227
+101% +$7.01M 0.24% 113
2019
Q2
$6.4M Buy
117,526
+79,366
+208% +$4.27M 0.1% 213
2019
Q1
$2.06M Buy
38,160
+1,587
+4% +$98K 0.04% 320
2018
Q4
$2.4M Buy
36,573
+35,395
+3,005% +$2.64M 0.05% 278
2018
Q3
$93K Sell
1,178
-296,224
-100% -$21.2M ﹤0.01% 919
2018
Q2
$19.1M Sell
297,402
-7,299
-2% -$481K 0.47% 49
2018
Q1
$19M Buy
304,701
+89,706
+42% +$6.44M 0.45% 52
2017
Q4
$15.6M Sell
214,995
-102,290
-32% -$7.44M 0.4% 68
2017
Q3
$25.8M Sell
317,285
-10,030
-3% -$793K 0.62% 34
2017
Q2
$26.3M Sell
327,315
-16,058
-5% -$1.27M 0.69% 32
2017
Q1
$27M Buy
343,373
+29,611
+9% +$2.36M 0.71% 25
2016
Q4
$24.8M Buy
313,762
+105,273
+50% +$8.52M 0.74% 25
2016
Q3
$18.6M Sell
208,489
-2,342
-1% -$221K 0.82% 24
2016
Q2
$20.2M Sell
210,831
-46,342
-18% -$4.62M 1.04% 17
2016
Q1
$26.7M Sell
257,173
-193,641
-43% -$18.8M 1.37% 8
2015
Q4
$44.1M Buy
450,814
+52,625
+13% +$5.15M 1.9% 5
2015
Q3
$38.4M Sell
398,189
-95,338
-19% -$10M 1.64% 5
2015
Q2
$51.8M Buy
493,527
+25,845
+6% +$2.64M 2.05% 3
2015
Q1
$48.3M Sell
467,682
-55,731
-11% -$5.64M 1.78% 4
2014
Q4
$50.4M Buy
523,413
+18,058
+4% +$1.59M 1.91% 3
2014
Q3
$40.2M Buy
505,355
+34,674
+7% +$2.73M 1.65% 4
2014
Q2
$35.5M Buy
470,681
+27,373
+6% +$2.07M 1.41% 8
2014
Q1
$33.2M Buy
443,308
+107,904
+32% +$7.62M 1.09% 9
2013
Q4
$24M Sell
335,404
-60,267
-15% -$3.87M 0.72% 28
2013
Q3
$22.5M Sell
395,671
-13,630
-3% -$812K 0.7% 32
2013
Q2
$23.4M Buy
+409,301
New +$23.7M 0.74% 29

Other funds holding CVS

PineBridge Investments's CVS Position: Q1 2026 in Review

PineBridge Investments opened a new position in CVS Health (CVS) in Q1 2026: 7,877 shares worth $566K. The stake represents ﹤0.01% of the portfolio and ranks #430 among its holdings. This is a return to the name: PineBridge Investments previously reported a position in CVS as recently as Q3 2025.

PineBridge Investments first reported a position in CVS in Q2 2013 and has held it in 48 quarters since. The position peaked at $51.8M in Q2 2015. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • PineBridge Investments held 7,877 shares of CVS Health worth $566K as of Q1 2026.
  • CVS Health was a new PineBridge Investments position in Q1 2026.
  • CVS Health made up ﹤0.01% of PineBridge Investments's portfolio in Q1 2026, its #430 holding.
  • PineBridge Investments first reported a position in CVS Health in Q2 2013 and has held it in 48 quarters since.
  • PineBridge Investments's CVS Health position peaked at $51.8M in Q2 2015.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on PineBridge Investments's 13F filing for Q1 2026, filed 14 May 2026.